Summary
FMC Corporation director Michael F. Barry reported a material insider purchase on a Form 4 filing with the Securities and Exchange Commission. On March 4, 2026, Barry purchased 18,072 shares of FMC common stock at a weighted average price of $13.83 per share, for a total consideration of approximately $249,938. The acquisition was executed by an attorney-in-fact, Sara Ponessa. After the transaction, Barry directly holds 19,634 FMC shares.
Insider purchase details
The Form 4 filing indicates the trade price range was between $13.77 and $13.86, with the weighted average recorded as $13.83. The insider buying occurred while the company’s stock has been under significant pressure - the share price is down 64% over the last 12 months and is trading at $14.39.
Financial results and valuation signals
FMC reported fourth-quarter 2025 earnings in which diluted earnings per share matched expectations at $1.20. Revenue for the quarter came in at $1.08 billion, below the $1.15 billion that had been anticipated. Separately, InvestingPro’s analysis cited in the filing describes FMC as trading below its Fair Value and lists the company among its Most Undervalued stocks.
Credit rating action and competitive pressures
Moody’s has downgraded FMC’s senior unsecured ratings to Ba1 from Baa3, a move characterized in the filing as a shift to junk status. The downgrade is attributed to patent expirations and rising competition in the generic crop protection chemicals market, factors Moody’s indicated negatively affect the company’s credit profile.
Board role and shareholder payout
The company has announced the election of Michael F. Barry to its board of directors. Barry will serve on the Audit and the Compensation and Human Capital committees. Additionally, FMC declared a quarterly cash dividend of $0.08 per share, payable April 16, 2026, to shareholders of record as of March 31, 2026.
Contextual note
The Form 4 filing and the company disclosures present a mix of signals: a director purchase concurrent with a sharp year-over-year decline in the stock, a beat/miss pattern in quarterly results, a credit-rating downgrade tied to industry-specific pressures, and a modest dividend payment schedule.